KPL vs SUDEEPPHRM: Stock Comparison

Kwality Pharmaceuticals Ltd vs Sudeep Pharma Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Sudeep Pharma Ltd is the larger company by market capitalisation. Kwality Pharmaceuticals Ltd shows a lower P/E, while Sudeep Pharma Ltd shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Kwality Pharmaceuticals Ltd and Sudeep Pharma Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, KPL is more favourable on 5 of 13 scored metrics and SUDEEPPHRM on 5These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SUDEEPPHRM is the larger company
₹9,731 Cr vs ₹2,692 Cr
P/E Ratio
KPL has a lower P/E
39.83x vs 56.17x
P/B Ratio
KPL has a lower P/B
8.09x vs 11x
EPS
KPL has higher earnings per share
₹64.9 vs ₹15.3
Qtr Sales Growth
KPL has stronger quarterly sales growth
35.8% vs 15.7%
Qtr Profit Growth
KPL has stronger quarterly profit growth
74.6% vs 10.6%
ROE
SUDEEPPHRM has a higher ROE
25.2% vs 22.8%
ROCE
SUDEEPPHRM has a higher ROCE
28.1% vs 24.2%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricKPLSUDEEPPHRM
Live Price₹2,590.4₹861.8
Day Change-4.34%0.43%
Volume26,3423.26 L
52-Week High₹2,890.3₹894.95
52-Week Low₹1,561₹524.05
Distance from 52W High-10.38%-3.7%

Valuation

MetricKPLSUDEEPPHRM
Market Cap₹2,692 Cr₹9,731 Cr
P/E Ratio39.83x56.17x
P/B Ratio8.09x11x
EPS₹64.9₹15.3
Book Value₹320₹78.2
Dividend Yield0%0%

Growth

MetricKPLSUDEEPPHRM
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth35.8%15.7%
Qtr Profit Growth74.6%10.6%

Profitability & Leverage

MetricKPLSUDEEPPHRM
ROE22.8%25.2%
ROCE24.2%28.1%
Net Margin13.39%27.14%
Operating Margin23.5%34.6%
Debt to Equity0.39x0.17x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricKPLSUDEEPPHRM
Promoter Holding54.87% 0.04 pp76.15%
FII Holding2.79% 2.29 pp1.81% 0.26 pp
DII Holding0.36% 0.03 pp15.65% 2.46 pp
Public Holding41.98% 2.36 pp6.39% 2.21 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Kwality Pharmaceuticals Ltd and Sudeep Pharma Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.